Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2000

View Archived Issues

La Jolla's lupus drug effective in patients with high-affinity antibodies

Cortex achieves first milestone in Organon agreement

Generex initiates long-term phase II trials of oral insulin formulation

Acadia and ArQule enter licensing agreement for lead serotonergic compounds

Vion expands TAPET trials, advances other products

SIB-1893 and other mGluR5 antagonists claimed for pain and anxiety

Fujisawa's new oxazole compounds particularly useful for glomerulonephritis

Chloride channel blockers as novel therapeutic approach to sickle cell disease and other disorders

Naphthalenecarboxamide-based tachykinin antagonists in development by AstraZeneca

Tanabe Seiyaku patents new inhibitors of PDE5

New lactones with anti-MRSA activity designed at Sankyo

Several new patents issued to Janssen for alpha2-adrenoceptor antagonists and their use

Memantine should be advanced to late-stage trials in PPN according to phase II results

Sepracor updates product development

TP-10 phase I/II study results presented at cardiovascular anesthesiology meeting

Nexell forms cell therapy and gene therapy alliance with Takara Shuzo

Ligand releases new data confirming Ontak's effectiveness in patients with severe psoriasis

Pregabalin phase I, phase II trials in painful peripheral neuropathy reported at AAN meeting

Therion's Prostvac vaccine shows promise in phase I prostate cancer study

United Therapeutics to begin Flolan-to-Uniprost transition study

AU-461 headed for development as a novel therapeutic agent for peptic ulcer

Medarex highlights Q1 developments marked by continued partnership arrangements

Pharmacological profile of SL-650472, a novel antiplatelet, antithrombotic agent

Elan completes acquisition of The Liposome Company

HCT-1026 enters phase II trials for overactive bladder

CNS-5161 being rapidly advanced to phase II for pain; development partner will be sought

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...